ConductScience.org, home

Paper1163426

Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.

Gray R and 5 others. Am Heart J, 1975. Cited by 184 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Papers, record 1163426. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1163426

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
PubMed
Journal
Am Heart J
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
184
iCite
Relative citation ratio, by iCite
8.77
iCite
Revised in PubMed
2019-06-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gray RR
2Chatterjee KK
3Vyden JKJ K
4Ganz WW
5Forrester JSJ S
6Swan HJH J

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
HemodynamicsMajor topic
Isosorbide DinitrateMajor topic
MyocardiumMajor topic
Administration, Oral
Adult
Aged
Blood Pressure
Cardiac Output
Coronary Circulation
Drug Evaluation
Female
Heart Rate
Humans
Lactates
Male
Middle Aged
Oxygen Consumption
Pulmonary Circulation
Tablets
Vascular Resistance
Venous Pressure

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.

PMIDTitleJournalYearIn PapersSource
28288687Effectiveness of isosorbide dinitrate in cyanide poisoning as a function of the administration timing.BMC Pharmacol Toxicol2017https://conductscience.org/library/papers/28288687PubMed
19379635Invasive monitoring in patients with heart failure.Curr Cardiol Rep2009https://conductscience.org/library/papers/19379635PubMed
7439242Effects and pharmacokinetics of isosorbide dinitrate in normal man.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7439242PubMed
7362716Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.Br Heart J1980https://conductscience.org/library/papers/7362716PubMed
7225252Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.Br Heart J1981https://conductscience.org/library/papers/7225252PubMed
6804202Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use.Drugs1982https://conductscience.org/library/papers/6804202PubMed
6797546Peripheral oedema in patients treated with isosorbide dinitrate.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6797546PubMed
6704264Acute haemodynamic and metabolic effects of felodipine in congestive heart failure.Br Heart J1984https://conductscience.org/library/papers/6704264PubMed
3533238Vasodilator therapy in the perioperative period.Can Anaesth Soc J1986https://conductscience.org/library/papers/3533238PubMed
3154699Combination of positive inotropic and vasodilating substances in congestive heart failure.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154699PubMed
3024949The treatment of heart failure. A methodological review of the literature.Drugs1986https://conductscience.org/library/papers/3024949PubMed
2113003Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2113003PubMed
884021Vasodilator treatment for acute and chronic heart failure.Br Heart J1977https://conductscience.org/library/papers/884021PubMed
821578Letter: Cardiac failure.Br Med J1976https://conductscience.org/library/papers/821578PubMed
687485Enhancement by isosorbide dinitrate of haemodynamic effects of dopamine in chronic congestive cardiac failure.Br Heart J1978https://conductscience.org/library/papers/687485PubMed
687484Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease.Br Heart J1978https://conductscience.org/library/papers/687484PubMed
534582Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.Br Heart J1979https://conductscience.org/library/papers/534582PubMed
497982Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.Can Med Assoc J1979https://conductscience.org/library/papers/497982PubMed
371647Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure.Br Heart J1979https://conductscience.org/library/papers/371647PubMed
359015Methods for the assessment of the effects of drugs on coronary blood flow in man.Br J Clin Pharmacol1978https://conductscience.org/library/papers/359015PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1163426

GET https://conductscience.org/api/papers/v1/1163426/authors